(Q44356850)

2 December 2017

Onset of major depression during treatment for nicotine dependence (English)

1 reference

2 December 2017

0 references

4

Chris Hayward

1 reference

2 December 2017

2

Stephen P Fortmann

1 reference

2 December 2017

Joel D Killen

1

1 reference

PubMed ID

12628619

2 December 2017

Alan Schatzberg

series ordinal

3

1 reference

PubMed ID

12628619

2 December 2017

Ann Varady

series ordinal

5

1 reference

2 December 2017

1 April 2003

1 reference

2 December 2017

1 reference

2 December 2017

28

1 reference

2 December 2017

3

1 reference

2 December 2017

461-470

1 reference

Depression and the dynamics of smoking. A national perspective

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4603%2801%2900266-0

7 January 2021

Major depression following smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4603%2801%2900266-0

7 January 2021

Effect of history of alcoholism or major depression on smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4603%2801%2900266-0

7 January 2021

Self-reported distress: analog or Ersatz depression?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4603%2801%2900266-0

7 January 2021

Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4603%2801%2900266-0

7 January 2021

Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4603%2801%2900266-0

7 January 2021

Nicotine, negative affect, and depression

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4603%2801%2900266-0

7 January 2021

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4603%2801%2900266-0

7 January 2021

Improved gas chromatographic method for the determination of nicotine and cotinine in biologic fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4603%2801%2900266-0

7 January 2021

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4603%2801%2900266-0

7 January 2021

Nicotine patch and paroxetine for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4603%2801%2900266-0

7 January 2021

Neurobiological similarities in depression and drug dependence: a self-medication hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4603%2801%2900266-0

7 January 2021

Development of depression during placebo-controlled trials of bupropion for smoking cessation: case reports

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4603%2801%2900266-0

7 January 2021

Has the California tobacco control program reduced smoking?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4603%2801%2900266-0

7 January 2021

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4603%2801%2900266-0

7 January 2021

Development of major depression after treatment for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4603%2801%2900266-0

7 January 2021

Interactive effects of depression symptoms, nicotine dependence, and weight change on late smoking relapse.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4603%2801%2900266-0

7 January 2021

Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for smoking relapse prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4603%2801%2900266-0

7 January 2021

10.1016/S0306-4603(01)00266-0

Identifiers

DOI

1 reference

2 December 2017

1 reference

PubMed ID

12628619